Vaxxa AB Sees Modest EBITDA Gain, Eyes Positive Cash Flow in Q4 Amid Digital Platform Launch
Vaxxa AB, a Swedish biotechnology company, reported modest third-quarter financial results, but anticipates positive cash flow in the fourth quarter due to the expected ramp-up of its digital platform’s usage.
3 minutes to read